Clinical importance of provider-reported HIV symptoms compared with patient-report

Medical Care

Volumn 39, Issue 4, 2001, Pages 397-408

  Justice, A C ^a,d   Chang, C H ^a   Rabeneck, L ^b   Zackin, R ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c HARVARD UNIVERSITY   (United States)

^d Veterans Administration Pittsburgh Health Center   (United States)

Author keywords

Adverse drug reactions; Health related quality of life; Provider report; Self report; Symptoms

Indexed keywords

ADULT; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MULTICENTER STUDY; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION;

ADULT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; QUALITY OF LIFE; SELF ASSESSMENT (PSYCHOLOGY);

EID: 0035321552     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-200104000-00010     Document Type: Article

References (25)

1. Kroenke K, Price RK. Symptoms in the community. Prevalence, classification, and psychiatric comorbidity. Arch Intern Med 1993;153:2474-80.
2. Justice AC, Rabeneck L, Hays RD, et al. Committee of the AIDS Clinical Trials Group. Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: a comparison with self-reported symptoms. J Acquir Immune Defic Synd 1999;21:126-33.
3. Cunningham WE, Shapiro MF, Hays RD, et al. Constitutional symptoms and health-related quality of life in patients with symptomatic HIV disease. Am J Med 1998;104:129-36.
4. Wilson IB, Cleary PD. Clinical predictors of declines in physical functioning in persons with AIDS: results of a logitudinal study. J AIDS 1997;16:343-9.
5. Wilson IB, Cleary PD. Clinical predictors of functioning in persons with acquired immunodeficiency syndrome. Med Care 1996;34:610-23.
6. Cleary PD, Fowler FJ, Weissman J, et al. Health-related quality of life in persons with acquired immune deficiency syndrome. Med Care 1993;31:569-80.
7. Ottervanger JP, Valkenburg HA, Grobbee DE, et al. Differences in perceived and presented adverse drug reactions in general practice. J Clin Epidemiol 1998;51:795-9.
8. Anderson RB, Testa MA. Symptom distress checklists as a component of quality of life measurement: comparing prompted reports by patient and physician with concurrent adverse event reports via the physician. Drug Inform J 1994;28:89-114.
9. Wyshak G, Barsky AJ. Relationship between patient self-ratings and physician ratings of general health, depression, and anxiety. Arch Fam Med 1994;3;419-24.
10. Stephens RJ, Hopwood P, Girling DJ, et al. Randomized trials with quality of life endpoints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings? Qual Life Res 1997;6:225-36.
11. Fontaine A, Laure F, Lassauniere JM, et al. Recognition of the symptoms experienced by HIV patients: how reliable? J Pain Symptom Manage. 99 A.D.;18:263-70.
12. Hammer SM, Katzenstein DA, Hughes MD, et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. N Engl J Med 1996;335:1081-90.
13. Lenderking WR, Testa MA, Katzenstein DA, et al. Measuring quality of life in early HIV disease: the modular approach. Qual Life Res 1997;6:515-30.
14. Stewart AL, Hays RD, Ware JE. The MOS short-form general health survey: reliability and validity in a patient poulation. Med Care 1988;26:724-35.
15. Jette AM, Davies AR, Cleary PD. The functional status questionnaire: reliability and validity when used in primary care. J Gen Intern Med 1986;1:143-9.
16. Katzenstein DA, Hammer SM, Hughes MD, et al. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. N Engl J Med 1996;335:1091-8.
17. Sackett DL, Haynes BR, Guyatt G, et al. Clinical epidemiology: A basic science for clinical medicine. Boston/Toronto: Little, Brown, and Company; 1991.
18. Harrell FE, Jr., Califf RM, Pryor DB, et al. Evaluating the yield of medical tests. JAMA 1982;247:2543-6.
19. Harrell FE, Lee KL, Mark DB. Tutorial in biostatistics. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-87.
20. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
21. Sinclair G, Justice AC, Wagner J, et al. HIV care providers do not appreciate the full range of their patients' symptoms. J Gen Intern Med 1999;15: [Abstract].
22. Cunningham WE, Bozzette SA, Hays RD, et al. Comparison of health-related quality of life in clinical trial and nonclinical trial human immunodeficiency virus-infected cohorts. Med Care 1995;33:AS15-AS25
23. Mathews WC, McCutchan JA, Asch S, et al. National estimates of HIV-related symptom prevalence from the HIV cost and services utilization study. Med Care 2000;38:750-62.
24. Osoba D. Self-rating symptom checklists: a simple method for recording and evaluating symptom control in oncology. Cancer Treat Rev 1993;19:43-51.
25. Rubenstein LV, McCoy JM, Cope DW, et al. Improving patient quality of life with feedback to physicians about functional status. JGIM 1995;10: 607-14.